483 Chongqing Daxin Pharmaceutical May 2018

483 Chongqing Daxin Pharmaceutical May 2018

$119 - Not in Stock

FDA investigators audited the Chongqing Daxin Pharmaceutical - Chongqing, China facility and issued inspectional observations (via FDA 483) on 11 May 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 11 May 2018
  • Location: Chongqing, China
  • FEI: 3000291692

Pre-Order Not Available